 |
|
|
Carlos O. Esquivel
Profile: http://med.stanford.edu/profiles/Carlos_Esquivel/
Contact: Academic Appointments
Appointment
Organization
Professor - Med Center Line
Surgery ;
|
Honors & Awards
Title
Organization
Date(s)
The Arnold and Barbara Silverman, Professor of Pediatric Transplantation
Stanford University
1999
Member
American Surgical Association
1997
Man of the Year
Costa Rica
1991
Fellow
American College of Surgeons
1990
National Research Service Award
NIH
1980
Administrative Appointments
Title
Organization
Start Year
End Year
Director, Pediatric Liver Transplant Program
Stanford University
1995
-
Vice Chairman, Department of Surgery
Stanford University
1995
1997
Director, Multiorgan Transplant Fellowship
Stanford University
1998
-
Associate Director, Institute for Immunity, Transplantation and Infection
Stanford University
2004
-
Chief, Division of Transplantation
Stanford University
1998
-
6 appointments: view full list
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
Fellowship
University of Pittsburgh
Transplantation
1985
Residency
University of California, Davis
Surgery
1984
Internship
University of California, Davis
Surgery
1978
Ph.D.
University of Lund, Sweden
Medicine
1983
MD
University of Costa Rica
Medicine
1975
Postdoctoral Advisees
Arvand Elihu
Research Interests
My role in research is to bring clinical problems to the laboratory to find answers, which in turn, will improve patient care. Thus, my role is translational research in the field of liver and small bowel transplantation. The limiting factor in transplantation is the scarcity of organs leading to pretransplant mortality as high as 20%. Improvements in organ preservation would make more organs available to transplant centers. Our current efforts aim to study the effect of anti-freeze proteins on preservation of the liver and intestine. Our laboratories are also investigating mechanisms to induce immunotolerance after solid organ transplantation and to isolate markers that can document it. This has the potential to be very beneficial in clinical transplantation. Finally, the mechanisms by which EBV infections lead to lymphoid proliferation is also under investigation in our laboratories.
Publications
- Berquist RK, Berquist WE, Esquivel CO, Cox KL, Wayman KI, Litt IF "Non-adherence to post-transplant care: Prevalence, risk factors and outcomes in adolescent liver transplant recipients." Pediatr Transplant 2008; 12: 2: 194-200 More »
- Stenard F, Nguyen C, Cox K, Kambham N, Umetsu DT, Krams SM, Esquivel CO, Martinez OM "Decreases in circulating CD4(+)CD25(hi)FOXP3(+) cells and increases in intragraft FOXP3(+) cells accompany allograft rejection in pediatric liver allograft recipients." Pediatr Transplant 2008; More »
- Beaunoyer M, Vanatta JM, Ogihara M, Strichartz D, Dahl G, Berquist WE, Castillo RO, Cox KL, Esquivel CO "Outcomes of transplantation in children with primary hepatic malignancy." Pediatr Transplant 2007; 11: 6: 655-660 More »
- Riddle-Taylor E, Nagasaki K, Lopez J, Esquivel CO, Martinez OM, Krams SM "Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury." Transplantation 2007; 84: 6: 778-85 More »
- Boyd SD, Stenard F, Lee DK, Goodnough LT, Esquivel CO, Fontaine MJ "Alloimmunization to red blood cell antigens affects clinical outcomes in liver transplant patients." Liver Transpl 2007; 13: 12: 1654-61 More »
60 publications: view full list
